Home insemination is a technique of fertilization that contains sperm placed into the reproductive tract of the female by using a syringe. This method often suits for lesbian couples, single women, and infertile couples. Some people are completely sub-fertile, infertile, and unexplained infertility. Most of couples experience difficulties while first try to conceive. These peoples prefers home insemination before turning to In-Vitro Fertilization (IVF) procedure. This procedure is done at home by using insemination kit that includes semen containers, ovulation tests, syringes, and other items to aid conception. Some kits includes ovulation predictor kits, since the technique is time important based on the female menstrual cycle. Insemination at home has several advantages such as involvement of partner, relaxed environment, use of fresh sperm, high pregnancy rates and low cost for procedure. Home artificial insemination is permitted in most of countries, but there are some legalities of insemination that has to be followed. However, there are no comprehensive or perfect standards regarding home insemination. Currently fertility law is strictly followed in developed countries such as U.S. and U.K. Changing lifestyle with rising focus of modern women regarding planned and reproductive lives. Many modern career oriented women are postponing childbearing due to uninterrupted full time career. This factor compels the need for home insemination product that drives the growth of the market. Also, the factors such as low cost in comparison to other fertilization procedures and growing cases of male infertility are the other factors that boost the growth of the market within the forecast period. However, the market is facing some challenges such as safety issue, ethical concerns, and high risk of transmission of sexual transmitted diseases. This factors restraining the adoption of home insemination kits which hampers the growth of home insemination market.
Get Sample Copy of this Report at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16181
The global home insemination market has been segmented on the basis of product type, technique and geography. In terms of product type, the home insemination market has been categorized into insemination kits, home conception devices, and accessories. Furthermore, insemination kits will dominate the total home insemination segment due increasing adoption of these kits among women from developed countries and as a result will hold major market share in present scenario. Cost-efficiency of home insemination kits and ongoing research on improving quality and success rate of pregnancy through artificial insemination would create an attractive growth opportunities for the Home insemination market. Also, emerging trend of delayed pregnancies among women, and the surge in health-care spending and disposable income have significantly contributed to the growth of the global home insemination market. Rising social acceptance has also played an important role in this home insemination market.
Geographically, North America accounts for a significant share in the market for home insemination owing to major demand from U.S. market. The demand for home insemination kits in the U.S. has been significantly influenced by higher levels of disposable income and the improving economic conditions. Europe was witnessed to be the second large market in the home insemination due to enhanced parenthood processes and high rate of miscarriages/infertility in the region. Asia pacific is expected to increase at rapid pace in upcoming years owing to contribution of countries such as India and China. Latin American, Brazil is expected to have considerable potential for driving the market growth due to high disposable income on healthcare concerns. The global market for home insemination is fragmented with presence of many vendors that operate at local level as well as in international market. The major players operating in this market include include Boots Pharmaceuticals, Clearblue, Church & Dwight Co., Inc., The Stork Ib2C, Inc., Conceivex, Bescot Healthcare, Insemination Supplies LLC, Kate & Duck among other significant players worldwide.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453